{"id":{"repo_id":"rowan","oai_identifier":"oai:rdw.rowan.edu:etd-4306"},"canonical_url":"https://search.ndltd.org/etd/rowan/oai:rdw.rowan.edu:etd-4306","repository":{"repo_id":"rowan","name":"Rowan University","base_url":"https://rdw.rowan.edu/do/oai/"},"display":{"title":"INTEGRATING DATA-DRIVEN AND MECHANISM-DRIVEN MODELING IN DRUG DISCOVERY AND HEPATOTOXICITY EVALUATION","abstract":"The pharmacological activities and hepatotoxicity significantly influence the success or failure of new drugs during drug discovery and development. Traditional experimental methods, such as animal models, are costly and time-consuming for chemical testing. There is a great need to develop in vitro and computational modeling to help identify the pharmacological activities and hepatotoxicity potential in the early stage of drug discovery and safety evaluation. In this dissertation, new computational models and associated modeling frameworks were described for predicting the biological profile and hepatotoxicity of chemicals. Firstly, a novel data mining and Quantitative Structure-Activity Relationship (QSAR) workflow was developed to construct a virtual bioprofile for opioids, facilitating the screening of new analgesic opioids. Next, a mechanistic model consisting of structural alerts and in vitro ARE activation was developed to predict chemical hepatotoxicity potentially mediated through the oxidative stress pathway. Lastly, an interpretable deep neural network approach, incorporating in vitro assay results, transcriptome data, and pathway ontology knowledge, was employed to construct a virtual adverse outcome pathway network encompassing various toxicity pathways. This model's interpretation can unveil potential toxicity mechanisms, aiding in identifying chemicals and drugs of concern to human health.","abstract_html":"The pharmacological activities and hepatotoxicity significantly influence the success or failure of new drugs during drug discovery and development. Traditional experimental methods, such as animal models, are costly and time-consuming for chemical testing. There is a great need to develop in vitro and computational modeling to help identify the pharmacological activities and hepatotoxicity potential in the early stage of drug discovery and safety evaluation. In this dissertation, new computational models and associated modeling frameworks were described for predicting the biological profile and hepatotoxicity of chemicals. Firstly, a novel data mining and Quantitative Structure-Activity Relationship (QSAR) workflow was developed to construct a virtual bioprofile for opioids, facilitating the screening of new analgesic opioids. Next, a mechanistic model consisting of structural alerts and in vitro ARE activation was developed to predict chemical hepatotoxicity potentially mediated through the oxidative stress pathway. Lastly, an interpretable deep neural network approach, incorporating in vitro assay results, transcriptome data, and pathway ontology knowledge, was employed to construct a virtual adverse outcome pathway network encompassing various toxicity pathways. This model&#x27;s interpretation can unveil potential toxicity mechanisms, aiding in identifying chemicals and drugs of concern to human health.","abstract_has_math":false,"creators":["Jia, Xuelian"],"institution":null,"degree_name":"Doctor of Philosophy (Ph.D.) in Pharmaceutical Chemistry","degree_level":"Dissertation","degree_discipline":"Chemistry and Biochemistry","degree_department":null,"school":null,"contributors":["Hao Zhu, Ph.D.","Zhiwei Liu, Ph.D.","Zhihong Wang, Ph.D"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-19T08:59:46Z","subjects":["adverse outcome pathway;deep learning;interpretable machine learning;machine learning;mechanistic modeling;QSAR","Drug development","Hepatotoxicology","Opioids","Chemistry","Medicinal-Pharmaceutical Chemistry","Pharmacy and Pharmaceutical Sciences"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://rdw.rowan.edu/etd/3300","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://rdw.rowan.edu/etd/3300","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://rdw.rowan.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Ardw.rowan.edu%3Aetd-4306","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Hao Zhu, Ph.D.","Zhiwei Liu, Ph.D.","Zhihong Wang, Ph.D"]},{"key":"dc:creator","label":"Author","values":["Jia, Xuelian"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2026-09-27T07:00:00Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2024-09-27T07:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Chemistry and Biochemistry"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Dissertation"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Doctor of Philosophy (Ph.D.) in Pharmaceutical Chemistry"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["adverse outcome pathway;deep learning;interpretable machine learning;machine learning;mechanistic modeling;QSAR","Drug development","Hepatotoxicology","Opioids","Chemistry","Medicinal-Pharmaceutical Chemistry","Pharmacy and Pharmaceutical Sciences"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://rdw.rowan.edu/etd/3300"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["The pharmacological activities and hepatotoxicity significantly influence the success or failure of new drugs during drug discovery and development. Traditional experimental methods, such as animal models, are costly and time-consuming for chemical testing. There is a great need to develop in vitro and computational modeling to help identify the pharmacological activities and hepatotoxicity potential in the early stage of drug discovery and safety evaluation. In this dissertation, new computational models and associated modeling frameworks were described for predicting the biological profile and hepatotoxicity of chemicals. Firstly, a novel data mining and Quantitative Structure-Activity Relationship (QSAR) workflow was developed to construct a virtual bioprofile for opioids, facilitating the screening of new analgesic opioids. Next, a mechanistic model consisting of structural alerts and in vitro ARE activation was developed to predict chemical hepatotoxicity potentially mediated through the oxidative stress pathway. Lastly, an interpretable deep neural network approach, incorporating in vitro assay results, transcriptome data, and pathway ontology knowledge, was employed to construct a virtual adverse outcome pathway network encompassing various toxicity pathways. This model's interpretation can unveil potential toxicity mechanisms, aiding in identifying chemicals and drugs of concern to human health."]},{"key":"dc:title","label":"Title","values":["INTEGRATING DATA-DRIVEN AND MECHANISM-DRIVEN MODELING IN DRUG DISCOVERY AND HEPATOTOXICITY EVALUATION"]}]}],"canonical_facts":{"dc:contributor":["Hao Zhu, Ph.D.","Zhiwei Liu, Ph.D.","Zhihong Wang, Ph.D"],"dc:creator":["Jia, Xuelian"],"dc:date.available":["2026-09-27T07:00:00Z"],"dc:date.created":["2024-09-27T07:00:00Z"],"dc:description.abstract":["The pharmacological activities and hepatotoxicity significantly influence the success or failure of new drugs during drug discovery and development. Traditional experimental methods, such as animal models, are costly and time-consuming for chemical testing. There is a great need to develop in vitro and computational modeling to help identify the pharmacological activities and hepatotoxicity potential in the early stage of drug discovery and safety evaluation. In this dissertation, new computational models and associated modeling frameworks were described for predicting the biological profile and hepatotoxicity of chemicals. Firstly, a novel data mining and Quantitative Structure-Activity Relationship (QSAR) workflow was developed to construct a virtual bioprofile for opioids, facilitating the screening of new analgesic opioids. Next, a mechanistic model consisting of structural alerts and in vitro ARE activation was developed to predict chemical hepatotoxicity potentially mediated through the oxidative stress pathway. Lastly, an interpretable deep neural network approach, incorporating in vitro assay results, transcriptome data, and pathway ontology knowledge, was employed to construct a virtual adverse outcome pathway network encompassing various toxicity pathways. This model's interpretation can unveil potential toxicity mechanisms, aiding in identifying chemicals and drugs of concern to human health."],"dc:identifier":["https://rdw.rowan.edu/etd/3300"],"dc:subject":["adverse outcome pathway;deep learning;interpretable machine learning;machine learning;mechanistic modeling;QSAR","Drug development","Hepatotoxicology","Opioids","Chemistry","Medicinal-Pharmaceutical Chemistry","Pharmacy and Pharmaceutical Sciences"],"dc:title":["INTEGRATING DATA-DRIVEN AND MECHANISM-DRIVEN MODELING IN DRUG DISCOVERY AND HEPATOTOXICITY EVALUATION"],"thesis:degree_discipline":["Chemistry and Biochemistry"],"thesis:degree_level":["Dissertation"],"thesis:degree_name":["Doctor of Philosophy (Ph.D.) in Pharmaceutical Chemistry"]},"updated_at":"2026-11-19T08:59:46Z"}